Using a new endoscopy technique for bariatric patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of the EvoEndo Endoscopy system for assessing and managing upper gastrointestinal diseases in bariatric patients. It focuses on transnasal endoscopy (TNE), which allows for a less invasive approach compared to traditional sedated oral endoscopy. The study aims to determine if this ultra-slim, single-use endoscope can improve safety, reduce costs, and enhance access to endoscopic care for patients with obesity-related gastrointestinal conditions. By comparing TNE to standard procedures, the study seeks to address challenges such as delayed diagnoses and high costs associated with traditional endoscopy.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Patient 18 years of age and less than 90 years of age with clinically referred for esophagoscopy, gastroscopy, or esophagogastroduodenoscopy (EGD)
2. Cared for in metabolic and bariatric clinic

Exclusion Criteria:

1. Patient \<18 years of age
2. Medically contraindicated to perform EGD or TNE
3. Inability to provide informed consent

Where it's running

• Brigham and Women's Hospital
  Boston, Massachusetts, United States Recruiting

Study contacts

• Principal investigator: Christopher C. Thompson, MD, MSc — Brigham and Womens Hospital
• Study coordinator: Michele B Ryan, MS
• Email: mryan@bwh.harvard.edu
• Phone: 617-525-8266

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Testing HM17321 injections to find safe dose ranges in healthy and obese adults

  This study will try single and multiple doses of HM17321 injections in healthy adults and adults with obesity to see if they are safe and how the body processes the drug.

  Recruiting Phase 1 Hanmi Pharmaceutical Company Limited · Cincinnati, Ohio · NCT07219589

• Endoscopic treatment for overweight and mild obesity using Orbera365

  This study is testing whether the Orbera365 intragastric balloon can help people who are overweight or mildly obese lose weight over a year.

  Recruiting Kaiser Clinic and Hospital · Santo André, São Paulo · NCT06785233

• Adding naltrexone–bupropion extended‑release to sleeve gastrectomy to improve weight loss

  This trial will test whether taking naltrexone–bupropion extended‑release after sleeve gastrectomy helps adults with obesity lose more weight and improve related health problems.

  Recruiting Phase 4 Laval University · Québec, Quebec · NCT06620562

• Optimizing diet and physical activity for taxi drivers

  This study is trying to help taxi drivers who are overweight or obese make healthier choices about their diet and exercise through personalized support and tools.

  Recruiting Phase 2 Memorial Sloan Kettering Cancer Center · New York, New York · NCT05770570

• Endoscopic Antral Myotomy for Weight Loss

  This study is testing a new weight loss procedure called Pylorus Sparing Antral Myotomy to see if it helps people with obesity lose weight safely and effectively on its own.

  Recruiting Brigham and Women's Hospital · Boston, Massachusetts · NCT05711758

• Improving outcomes for patients with failed sleeve gastrectomy using a new surgical approach

  This study is testing a new type of surgery called SADI-S to see if it can help people who didn't have success with their previous sleeve gastrectomy lose weight and improve their health.

  Recruiting Laval University · Québec, Quebec · NCT05242835

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.